Abstract:
Heterocyclic compounds of the formula (I) and salts, preferably pharmaceutically acceptable salts thereof, are provided in which R, R1, R2, Q, m and n have the meanings explained in detail in the description. Also provided are a process for their preparation and the use of these compounds as medicaments, in particular as aldosterone synthase inhibitors.
Abstract:
The application relates to novel heterocyclic compounds of the general formula (I) and salts, preferably pharmaceutically acceptable salts, thereof in which R, R1, R2, Q, m and n have the meanings explained in detail in the description, a process for their preparation and the use of these compounds as medicaments, in particular as aldosterone synthase inhibitors.
Abstract:
The application relates to novel amino alcohols of the general formula (I) where R, R1, R2, R3, R4, R5 and R6 each have the definitions illustrated in detail in the description, to a process for their preparation and to the use of these compounds as medicines, in particular as renin inhibitors.
Abstract:
Compounds of the general formula (formula I) in which the meanings of the substituents R1 to R6 are as indicated in claim 1, have renin-inhibiting properties and can be used as medicines.
Abstract:
The patent application relates to new heterocyclic compounds of the general formula (I) in which R, R1, R2, W, X, Y, Z and n have the definitions elucidated in more detail in the description, to a process for preparing them and to the use of these compounds as medicaments, particularly as aldosterone synthase inhibitors.
Abstract:
Compounds of the general formula (I) in which the meanings of the substituents R1 and R2 are as stated in claim 1, have renin-inhibiting properties and can be used as medicines.
Abstract:
Substituted piperidines of formulae (I) and (II) with the substituent definitions as explained in the specification. The compounds are suitable in particular as renin inhibitors and are highly potent.
Abstract:
Use of compounds of the general formula (I) and pharmaceutically acceptable salt thereof, in which R1, R2, R3, R4, W, X and Z, n and m have the definitions illustrated in detail in the description, as beta-secretase, cathepsin D, plasmepsin II and/or HIV protease inhibitors.
Abstract translation:使用通式(I)的化合物及其药学上可接受的盐,其中R 1,R 2,R 3,R 3, SEQ ID NO:4,W,X和Z,n和m具有在说明书中详细说明的定义,如β-分泌酶,组织蛋白酶D,浆细胞素II和/或HIV蛋白酶抑制剂。
Abstract:
The application relates to novel amino alcohols of the general formula (I) where R, R1, R2, R3, R4, R5 and R6 each have the definitions illustrated in detail in the description, to a process for their preparation, and to the use of these compounds as medicines, in particular as renin inhibitors.
Abstract:
A moving image encoding and decoding system reduces compressed moving picture data amounts by producing a prediction signal suitable for moving pictures including dynamic textures. The system includes a moving picture encoding device 1 that includes a block divider 102 receiving a target pixel signal, a prediction signal generator 103 producing a prediction signal, a subtractor 105 producing a differential signal, and a transformer 106 and quantizer 107 producing an encoded differential signal. The encoding device 1 also includes an inverse quantizer 108 and inverse transformer 109 producing a decoded differential signal, an adder 110 producing a reproduction signal, a frame memory 104 storing the reproduction signal as a reference image, and a reference image generator 113. The reference image generator 113 may obtain an observation matrix C by using a pre-existing reference image. The encoding system 1 produces a new reference image y″t+5 based on the observation matrix C and a state vector xt+5, and stores the new reference image in the frame memory 104. The prediction signal generator 103 produces the prediction signal by using at least the new reference image y″t+5.